Orexigen Therapeutics, Inc. Logo Image

Orexigen Therapeutics, Inc.

Orexigen Therapeutics, Inc. Banner Image

Orexigen Therapeutics, Inc. has reached its limit for report views.

Please check back to see if Orexigen Therapeutics, Inc. has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2014 Form 10K, 2015 Annual Report

Orexigen Therapeutics, Inc.

Orexigen Therapeutics, Inc. does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

  • Orexigen Therapeutics, Inc.
  • Orexigen Therapeutics, Inc.
  • Orexigen Therapeutics, Inc.

About Orexigen Therapeutics, Inc.

51-200 Employees
Based in La Jolla, California

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. It has a collaboration agreement with Takeda Pharmaceutical Company Limited to develop and commercialize Contrave in Canada and Mexico. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California.

Ticker:
OREX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Drug Manufacturers - Other (See More Drug Manufacturers - Other Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol